These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Author: Paul E, Graef V, Ruppel R, Hellwich M.
    Journal: Z Hautkr; 1983 Feb 15; 58(4):262-5. PubMed ID: 6405551.
    Abstract:
    In case of uncharacteristic patient complaints or slightly pathologic BSR or liver enzyme levels in patients, suffering from melanoma, the determination of 5-S-cysteinyldopa in the 24-h-urine may be of great diagnostic value. If the complaints and the pathologic values are early symptoms and signs of generalized metastases being clinically not yet manifest, the excretion of 5-S-cysteinyldopa in the urine is often increased. In such cases, a thorough and possibly invasive search for metastases is indicated.
    [Abstract] [Full Text] [Related] [New Search]